Adjuvant treatment for stage I germ-cell testicular tumours: preliminary experience of the Spanish Germ-Cell Cancer Group

被引:0
|
作者
Germa-Lluch, JR [1 ]
机构
[1] Inst Catala Oncol, Div Med Oncol, Barcelona 08907, Spain
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [1] Treatment of stage I testicular germ-cell tumors
    J. Aparicio
    J. R. Germa
    Medical Oncology, 2006, 23 : 305 - 315
  • [2] Treatment of stage I testicular germ-cell tumors
    Aparicio, J.
    Germa, J. R.
    MEDICAL ONCOLOGY, 2006, 23 (03) : 305 - 315
  • [3] Testicular germ-cell cancer
    Bosl, GJ
    Motzer, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04): : 242 - 253
  • [4] Testicular germ-cell cancer
    Horwich, A
    Shipley, J
    Huddart, R
    LANCET, 2006, 367 (9512): : 754 - 765
  • [5] Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis:: the experience of the Spanish Germ-Cell Cancer Group (GG)
    Germà-Lluch, JR
    del Muro, XG
    Maroto, P
    Paz-Ares, L
    Arranz, JA
    Gumà, J
    Alba, E
    Sastre, J
    Aparicio, J
    Fernández, A
    Barnadas, A
    Terrassa, J
    Sáenz, A
    Almenar, D
    López-Brea, M
    Climent, MA
    Sánchez, MA
    de la Vega, RL
    Berenguer, G
    Pérez, C
    EUROPEAN UROLOGY, 2002, 42 (06) : 553 - 562
  • [6] Testicular germ-cell tumours in a broader perspective
    J. Wolter Oosterhuis
    Leendert H. J. Looijenga
    Nature Reviews Cancer, 2005, 5 : 210 - 222
  • [7] Genetic predisposition to testicular germ-cell tumours
    Lutke-Holzik, MF
    Rapley, EA
    Hoekstra, HJ
    Sleijfer, DT
    Nolte, IM
    Sijmons, RH
    LANCET ONCOLOGY, 2004, 5 (06): : 363 - 371
  • [8] Testicular germ-cell tumours in a broader perspective
    Oosterhuis, JW
    Looijenga, LHJ
    NATURE REVIEWS CANCER, 2005, 5 (03) : 210 - 222
  • [10] Treatment intensification in germ-cell tumours
    Droz, JP
    Biron, P
    Culine, S
    Kramar, A
    PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY 2, 1996, : 229 - 238